Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Externally used pharmaceutical composition for ophthalmic operation pre-operative prevention

A technology for topical medicine and ophthalmic surgery, applied in the direction of drug combination, drug delivery, medical formula, etc., can solve the problems of lack of growth factors, weakened white blood cell bactericidal power, and difficult treatment, so as to improve the catabolism speed of collagen and increase transdermal Absorption rate, effect of promoting wound healing

Inactive Publication Date: 2016-08-31
王丽
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The reasons are: the repair ability of local tissues in diabetic patients is reduced; and the increase of blood sugar causes protein synthesis to decrease, decomposition to increase, cell metabolism to be abnormal, fibroblast function at the wound to decrease, epithelial hyperplasia to reduce collagen deposition, and the tensile strength of the wound to decrease. Insufficient, when the wound heals, there is a lack of a growth factor from platelets, resulting in delayed or non-healed wound healing; high blood sugar weakens the bactericidal ability of white blood cells; antibacterial substances in the body (such as antibodies, complements, etc.) The hypoxia caused by the lesion creates an environment conducive to the reproduction of bacteria, and other reasons lead to complications of surgical incisions in diabetic patients, such as persistent bloody secretions and even delayed healing
In addition, the healing of diabetic patients after eye surgery is difficult, and it is difficult to deal with it. There are few preoperative intervention programs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1, the weight ratio of raw materials is: Guanyin bamboo 20g, wild rice 20g, loofah 8g, Chinese kale 6g, southern alfalfa 8g, Cimicifuga 7g, cow ear maple 3g, privet skin 10g, glutinous rice root 60g, calamus japonica 10g, Niaobusu 1g, decoction for external use.

[0025] The preparation method of Example 1 is: Avalokitesvara, wild rice, loofah, kale, southern alfalfa, cohosh, cow ear maple, privet skin, glutinous rice root, nine-section calamus, Niaobusu, wash and remove impurities, put Into the decoction casserole. Add cold water over the medicinal surface, soak for 60 minutes, fry with strong fire until boiling, then change to slow fire for 30 minutes, cook twice in total, filter the decoction with gauze, concentrate, take appropriate amount of sterile gauze for wet compress.

Embodiment 2

[0026] Example 2, the weight ratio of raw materials is: 10 parts of Guanyin bamboo, 25 parts of wild rice, 6 parts of loofah, 3 parts of kale, 12 parts of southern alfalfa, 10 parts of Cimicifuga, 2 parts of Aurantium japonica, 5 parts of privet skin , 60 parts of glutinous rice root, 15 parts of Jiujie calamus, and 3 parts of Niaobusu.

Embodiment 3

[0027] Example 3, the weight ratio of raw materials is: 20 parts of Guanyin bamboo, 20 parts of wild rice, 8 parts of loofah, 6 parts of kale, 8 parts of southern alfalfa, 7 parts of Cimicifuga, 3 parts of maple, 10 parts of privet skin , 100 parts of glutinous rice root, 10 parts of Jiujie calamus, 1 part of Niaobusu.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an externally used pharmaceutical composition for ophthalmic operation pre-operative prevention. The pharmaceutical composition is prepared from the following bulk drugs by weight: 10-30 parts of Bambusa multiplex, 15-25 parts of Zizania caduciflora, 6-10 parts of loofah sponge, 3-10 parts of Brassica alboglabra, 6-12 parts of Medicago hispida, 3-10 parts of Rhizoma Cimicifugae, 2-5 parts of Daphniphyllum calycinum, 5-15 parts of bark of ligustrum lucidum, 60-120 parts of root of oryza sativa L., 5-15 parts of rhizoma anemones altaicae, and 1-3 parts of Ilex cornuta. The agent provided by the invention has reasonable formula and clear curative effect, and can effectively reduce the incidence of undesirable wound healing in diabetic patient ophthalmic operation.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to an external pharmaceutical composition for ophthalmic surgery preoperative prevention. Background technique [0002] The eye is one of the most vulnerable target organs in diabetic patients, which can cause various eye complications such as cataract, external ophthalmoplegia, etc. According to reports, the average prevalence of retinopathy caused by diabetes is 50% to 63%. More than 50% of cataract patients are diabetic. [0003] Before ophthalmic surgery, the blood sugar control requirements for diabetic patients are the most stringent. For general surgery, preoperative blood sugar control requires fasting blood sugar to <10.0mmol / L, while eye surgery requires fasting blood sugar to <8.3mmol / L ( "Ophthalmology"), even <6.7mmol / L ("Handbook of Ophthalmology"). The reasons are: the repair ability of local tissues in diabetic patients is reduced; and the incre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P27/02A61P3/10A61P17/02
CPCA61K36/899A61K9/0014A61K36/185A61K36/25A61K36/31A61K36/42A61K36/48A61K36/638A61K36/71A61K36/898A61K2300/00
Inventor 王丽张学印
Owner 王丽
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products